Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT)

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) (USD $)
Common Stock
Additional Paid-In Capital
Retained Earnings / Accumulated Deficit
Total
Beginning balance, value at Dec. 31, 2012 $ 700 $ 143,447 $ (144,216) $ (69)
Beginning balance, shares at Dec. 31, 2012 7,000,000      
Shares issued for payments under PhytoSphere Agreement, shares 4,741,667      
Shares issued for payments under PhytoSphere Agreement, value 474 5,754,648   5,755,122
To record the value of the beneficial conversion feature of debt   637,400   637,400
Net loss     (476,362) (476,362)
Ending balance, value at Sep. 30, 2013 $ 1,174 $ 6,535,495 $ (620,578) $ 5,916,091
Ending balance, shares at Sep. 30, 2013 11,741,667